CanniMed Therapeutics

About:

CanniMed Ltd. is a plant biopharmaceutical company .

Website: https://www.cannimed.ca/

Twitter/X: cannimed

Description:

CanniMed Ltd. was established in 2013 to provide Canadian patients with access to a standardized and trusted supply of pharmaceutical-grade cannabis. Currently they operate under the Access to Cannabis for Medical Purposes Regulations(ACMPR) governed by Health Canada. Their history is much deeper, however. From 2000 - 2013 our parent company, Prairie Plant Systems, was the sole supplier to Health Canada of medical cannabis. As a result of over a decade and a half of hands-on experience, we have implemented standard procedures and processes that are in line with pharmaceutical manufacturing standards to ensure consistency of their products for Canadian patients.

Total Funding Amount:

$5.15M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Saskatoon, Saskatchewan, Canada

Founded Date:

2013-01-01

Contact Email:

info(AT)cannimed.com

Founders:

Brent Zettl

Number of Employees:

11-50

Last Funding Date:

2017-01-30

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai